top of page
455908_413618.webp

Our Mission

Digital mental health solutions that are accessible, affordable to all

At Cognitive Leap® Solutions Inc., we believe every child deserves the opportunity to thrive.

Headquartered in California, we are a neuroscience-driven technology company dedicated to transforming the future of mental health and neurodevelopmental care. For more than a decade, we have developed clinically validated, highly scalable digital solutions that support children with ADHD, ASD, and related challenges—helping to unlock abilities that might otherwise go unseen.

Through our subsidiaries and affiliates across the Americas and Asia-Pacific, we work across cultures and communities to make high-quality cognitive assessment and training more accessible and affordable worldwide.

By the end of 2025, we had helped tens of thousands of children take meaningful steps toward brighter futures—gaining confidence, strengthening focus, building independence, and discovering their unique strengths. Our solutions are trusted by hundreds of leading hospitals, therapy clinics, and schools, but our greatest measure of success is the renewed hope we see in families.

We are driven by one purpose: to make mental healthcare affordable and accessible to all, so that no child is left behind.

Our Global Reach

Cognitive Leap® technology is deployed across two continents through our regional operating partners.

加州优脑中心.png
Americas
GOGLEAP® AMERICAS
  • Centers in California:
    Irvine, Diamond Bar, San Jose

  • Qualified for California DDS reimbursement programs

  • Expanding across North America

资源 1_4x.png
Asia-Pacific
COGLEAP® ASIA
  • 100+ partner institutions including Grade-AAA hospitals

  • Coverage across 20+ provinces in Greater China

  • Thousands of children served through clinical networks

Academic Partnerships

PAU_Stacked_Logo_Blue_No-tagline.png
Palo Alto University

Practicum site for clinical psychology students gaining hands-on experience.

20220722171438493599.png
Sun Yat-sen University

Clinical trial collaboration with one of China's top medical institutions.

SM_Web_vert_LG.png
Stanford Medicine

Neurodiversity Project advisor relationship. HFS® outcomes presented at Neurodiversity Summit 2024.

Our Commitment to Evidence

We invest in rigorous clinical validation. Our solutions have been studied in multiple trials totaling 240+ participants, with results presented at major academic conferences and published for peer review.

bottom of page